Pharma Stocks To Buy 2017 -

: A top pick for dividends (yielding ~4.2%) and growth, with shares rising 45% in 2017 driven by Humira and its cancer drug pipeline.

: Gained over 700% after positive Phase 2 data for its epilepsy treatment, ganaxolone. pharma stocks to buy 2017

: Soared over 440% after announcing a gene therapy partnership with Pfizer . : A top pick for dividends (yielding ~4

: Gained 103% , evolving from a rare-disease specialist into a large-cap biotech giant. Blue-Chip & Dividend Leaders pharma stocks to buy 2017

For investors seeking stability and income, large-cap pharma stocks remained dominant through R&D investment and consistent payouts.